FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021716162> ?p ?o ?g. }

• W2021716162 endingPage "743" @default.
• W2021716162 startingPage "736" @default.
• W2021716162 abstract "The standard treatment of patients with stage I non-small cell lung cancer is resection of the primary tumor; however, the recurrence rate is 28% to 45%. This study evaluates a panel of molecular markers in a large population of patients with stage I non-small cell lung cancer to determine the prognostic value of each marker and to create a biologic risk model.Pathologic specimens were collected from 408 consecutive patients after complete resection for stage I non-small cell lung cancer at a single institution, with follow-up of at least 5 years. A panel of 10 molecular markers was chosen for immunohistochemical analysis of the primary tumor on the basis of differing oncogenic mechanisms. Local tumor expansion requires growth regulating proteins (epidermal growth factor receptor, the protooncogene erb-b2); apoptosis proteins (p53, bcl-2); and cell cycle regulating proteins (retinoblastoma recessive oncogene, KI-67). Local tumor invasion requires angiogenesis (factor viii). The development of distant metastases involves the expression of adhesion proteins (CD-44, sialyl-Tn, blood group A). Cox proportional hazards regression analysis was used to construct an independent risk model for cancer recurrence and death.Multivariable analysis demonstrated significantly elevated risk for the following molecular markers: p53 (hazard ratio, 1.68; P =.004); factor viii (hazard ratio, 1.47 P =. 033); erb-b2 (hazard ratio, 1.43; P =.044); CD-44 (hazard ratio, 1. 40; P =.050); and retinoblastoma recessive oncogene (hazard ratio, 0. 747; P =.084).Five molecular markers were associated with the risk of recurrence and death, representing independent metastatic pathways: apoptosis (p53), angiogenesis (factor viii), growth regulation (erb-b2), adhesion (CD-44), and cell cycle regulation (retinoblastoma recessive oncogene). This study demonstrates the validity of this molecular biologic risk model in patients with stage I non- small cell lung cancer." @default.
• W2021716162 created "2016-06-24" @default.
• W2021716162 creator A5001948668 @default.
• W2021716162 creator A5011590188 @default.
• W2021716162 creator A5018648604 @default.
• W2021716162 creator A5056277456 @default.
• W2021716162 creator A5059586699 @default.
• W2021716162 date "1999-04-01" @default.
• W2021716162 modified "2023-09-27" @default.
• W2021716162 title "A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers" @default.
• W2021716162 cites W109718055 @default.
• W2021716162 cites W1583699731 @default.
• W2021716162 cites W1921598063 @default.
• W2021716162 cites W1972311492 @default.
• W2021716162 cites W1975549289 @default.
• W2021716162 cites W1993312546 @default.
• W2021716162 cites W2014119635 @default.
• W2021716162 cites W2016571526 @default.
• W2021716162 cites W2016791457 @default.
• W2021716162 cites W2021329627 @default.
• W2021716162 cites W2030126960 @default.
• W2021716162 cites W2068776651 @default.
• W2021716162 cites W2070471589 @default.
• W2021716162 cites W2081709843 @default.
• W2021716162 cites W2087713471 @default.
• W2021716162 cites W2090460961 @default.
• W2021716162 cites W2100442886 @default.
• W2021716162 cites W2111585211 @default.
• W2021716162 cites W2148725505 @default.
• W2021716162 cites W2164763530 @default.
• W2021716162 cites W4293342355 @default.
• W2021716162 doi "https://doi.org/10.1016/s0022-5223(99)70294-1" @default.
• W2021716162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10096969" @default.
• W2021716162 hasPublicationYear "1999" @default.
• W2021716162 type Work @default.
• W2021716162 sameAs 2021716162 @default.
• W2021716162 citedByCount "219" @default.
• W2021716162 countsByYear W20217161622012 @default.
• W2021716162 countsByYear W20217161622013 @default.
• W2021716162 countsByYear W20217161622014 @default.
• W2021716162 countsByYear W20217161622015 @default.
• W2021716162 countsByYear W20217161622016 @default.
• W2021716162 countsByYear W20217161622017 @default.
• W2021716162 countsByYear W20217161622018 @default.
• W2021716162 countsByYear W20217161622019 @default.
• W2021716162 countsByYear W20217161622020 @default.
• W2021716162 countsByYear W20217161622021 @default.
• W2021716162 countsByYear W20217161622022 @default.
• W2021716162 countsByYear W20217161622023 @default.
• W2021716162 crossrefType "journal-article" @default.
• W2021716162 hasAuthorship W2021716162A5001948668 @default.
• W2021716162 hasAuthorship W2021716162A5011590188 @default.
• W2021716162 hasAuthorship W2021716162A5018648604 @default.
• W2021716162 hasAuthorship W2021716162A5056277456 @default.
• W2021716162 hasAuthorship W2021716162A5059586699 @default.
• W2021716162 hasBestOaLocation W20217161621 @default.
• W2021716162 hasConcept C104317684 @default.
• W2021716162 hasConcept C121608353 @default.
• W2021716162 hasConcept C126322002 @default.
• W2021716162 hasConcept C142724271 @default.
• W2021716162 hasConcept C143998085 @default.
• W2021716162 hasConcept C204232928 @default.
• W2021716162 hasConcept C207103383 @default.
• W2021716162 hasConcept C2776256026 @default.
• W2021716162 hasConcept C2776577112 @default.
• W2021716162 hasConcept C2781018059 @default.
• W2021716162 hasConcept C29537977 @default.
• W2021716162 hasConcept C44249647 @default.
• W2021716162 hasConcept C502942594 @default.
• W2021716162 hasConcept C50382708 @default.
• W2021716162 hasConcept C55493867 @default.
• W2021716162 hasConcept C71924100 @default.
• W2021716162 hasConcept C86803240 @default.
• W2021716162 hasConceptScore W2021716162C104317684 @default.
• W2021716162 hasConceptScore W2021716162C121608353 @default.
• W2021716162 hasConceptScore W2021716162C126322002 @default.
• W2021716162 hasConceptScore W2021716162C142724271 @default.
• W2021716162 hasConceptScore W2021716162C143998085 @default.
• W2021716162 hasConceptScore W2021716162C204232928 @default.
• W2021716162 hasConceptScore W2021716162C207103383 @default.
• W2021716162 hasConceptScore W2021716162C2776256026 @default.
• W2021716162 hasConceptScore W2021716162C2776577112 @default.
• W2021716162 hasConceptScore W2021716162C2781018059 @default.
• W2021716162 hasConceptScore W2021716162C29537977 @default.
• W2021716162 hasConceptScore W2021716162C44249647 @default.
• W2021716162 hasConceptScore W2021716162C502942594 @default.
• W2021716162 hasConceptScore W2021716162C50382708 @default.
• W2021716162 hasConceptScore W2021716162C55493867 @default.
• W2021716162 hasConceptScore W2021716162C71924100 @default.
• W2021716162 hasConceptScore W2021716162C86803240 @default.
• W2021716162 hasIssue "4" @default.
• W2021716162 hasLocation W20217161621 @default.
• W2021716162 hasLocation W20217161622 @default.
• W2021716162 hasOpenAccess W2021716162 @default.
• W2021716162 hasPrimaryLocation W20217161621 @default.
• W2021716162 hasRelatedWork W2161139902 @default.
• W2021716162 hasRelatedWork W2340130805 @default.
• W2021716162 hasRelatedWork W2772993264 @default.

• next